Publications by authors named "Helena Groth"
Article Synopsis
- This study investigates the effectiveness of adalimumab, an anti-TNFα agent, for treating childhood noninfectious uveitis (NIU) and aims to establish a therapeutic range for its trough levels.
- The research involved analyzing serum trough levels in 36 children treated with adalimumab, finding that those who fully responded had higher levels (average 11.8 μg/mL) than partial or non-responders (average 9.2 μg/mL).
- The suggested therapeutic range for optimal clinical effects was determined to be between 9.6 to 13 μg/mL, highlighting the importance of therapeutic drug monitoring to enhance treatment outcomes for these pediatric patients.